{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T18:54:49Z","timestamp":1776797689867,"version":"3.51.2"},"reference-count":40,"publisher":"Impact Journals, LLC","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2019,11,11]]},"DOI":"10.18632\/aging.102476","type":"journal-article","created":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T22:50:41Z","timestamp":1573512641000},"page":"10532-10556","source":"Crossref","is-referenced-by-count":13,"title":["Distinct effects of epirubicin, cisplatin and cyclophosphamide on ovarian somatic cells of prepuberal ovaries"],"prefix":"10.18632","volume":"11","author":[{"given":"Serena","family":"Marcozzi","sequence":"first","affiliation":[{"name":"Department of Biomedicine and Prevention, Section of Histology and Embryology, Faculty of Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerio","family":"Rossi","sequence":"additional","affiliation":[{"name":"Department of Biomedicine and Prevention, Section of Histology and Embryology, Faculty of Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Salvatore","sequence":"additional","affiliation":[{"name":"Department of Biomedicine and Prevention, Section of Histology and Embryology, Faculty of Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Di Rella","sequence":"additional","affiliation":[{"name":"Medical Oncology, Department of Senology, National Cancer Institute, IRCCS Foundation G. Pascale, Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"De Felici","sequence":"additional","affiliation":[{"name":"Department of Biomedicine and Prevention, Section of Histology and Embryology, Faculty of Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca Gioia","family":"Klinger","sequence":"additional","affiliation":[{"name":"Department of Biomedicine and Prevention, Section of Histology and Embryology, Faculty of Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2019,11,11]]},"reference":[{"key":"1","first-page":"604","article-title":"Incidence of premature ovarian failure.","volume":"6","author":"Annegers","year":"1986","journal-title":"Obstet Gynecol"},{"key":"2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13633-015-0009-z","article-title":"Primary ovarian insufficiency in adolescents: a case series.","volume":"201","author":"Bachrach","year":"2015","journal-title":"International Journal of Pediatric Endocrinology"},{"key":"3","volume-title":"Embriologia umana.","author":"De Felici","year":"2013"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1016\/b978-012444562-8\/50003-3","article-title":"Dynamics of Human Follicular Growth: Morphologic, Dynamic, and Functional Aspects.","author":"Gougeon","year":"2004","journal-title":"The ovary, second edition"},{"key":"5","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1210\/edrv-15-6-707","article-title":"Ovarian follicle atresia: a hormonally controlled apoptotic process.","volume":"1","author":"Tsafriri","year":"1994","journal-title":"Endocr Rev"},{"key":"6","doi-asserted-by":"publisher","first-page":"549","DOI":"10.23736\/S0026-4784.18.04274-0","article-title":"Programmed cell death in the human ovary.","volume":"7","author":"Klinger","year":"2018","journal-title":"Minerva Ginecol"},{"key":"7","doi-asserted-by":"publisher","first-page":"e8772","DOI":"10.1371\/journal.pone.0008772","article-title":"Human ovarian reserve from conception to the menopause.","volume":"5","author":"Kelsey","year":"2010","journal-title":"PLoS One"},{"key":"8","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1093\/humrep\/dem408","article-title":"A new model of reproductive aging: the decline in ovarian non-growing follicle number from birth to menopause.","volume":"2","author":"Klein","year":"2008","journal-title":"Hum Reprod"},{"key":"9","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1093\/humrep\/dew027","article-title":"ESHRE Guideline: management of women with premature ovarian insufficiency.","volume":"3","author":"Vermeulen","year":"2016","journal-title":"Hum Reprod"},{"key":"10","unstructured":"American Cancer Society, Merck KGaA. Global burden of cancer in women. Current status, trends, and interventions. 2016."},{"key":"11","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1200\/JCO.2017.76.3441","article-title":"Reproductive Function and Outcomes in Female Survivors of Childhood, Adolescent, and Young Adult Cancer: A Review.","volume":"3","author":"Wallace","year":"2018","journal-title":"J Clin Oncol"},{"key":"12","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1002\/cncr.21646","article-title":"Gonadotropin-releasing hormone analogues added to adjuvant chemotherapy protect ovarian function and improve clinical outcomes in young women with early breast carcinoma.","volume":"10","author":"Rea","year":"2006","journal-title":"Cancer"},{"key":"13","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1515\/JPEM.2003.16.6.835","article-title":"Characterization of early presentation idiopathic ovarian failure in girls and adolescents.","volume":"1","author":"Wasniewska","year":"2003","journal-title":"J Pediatr Endocrinol Metab"},{"key":"14","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3109\/09513591003632274","article-title":"Response to hormonal treatment of young females with primary or very premature ovarian failure.","volume":"2","author":"Creatsas","year":"2011","journal-title":"Gynecol Endocrinol"},{"key":"15","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.3802\/jgo.2016.27.e22","article-title":"Toward precision medicine for preserving fertility in cancer patients: existing and emerging fertility preservation options for women.","volume":"2","author":"Woodruff","year":"2016","journal-title":"J Gynecol Oncol"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmz027","article-title":"Ovarian damage from chemotherapy and current approaches to its protection.","author":"Klinger","year":"2019","journal-title":"Hum Reprod Update"},{"key":"17","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/cdd.2016.97","article-title":"LH prevents cisplatin-induced apoptosis in oocytes and preserves female fertility in mouse.","volume":"2","author":"Klinger","year":"2017","journal-title":"Cell Death Differ"},{"key":"18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1095\/biolreprod.111.095208","article-title":"Temporal differences in granulosa cell specification in the ovary reflect distinct follicle fates in mice.","volume":"8","author":"Capel","year":"2012","journal-title":"Biol Reprod"},{"key":"19","doi-asserted-by":"publisher","first-page":"6934","DOI":"10.1038\/ncomms7934","article-title":"Lineage specification of ovarian theca cells requires multicellular interactions via oocyte and granulosa cells.","volume":"6","author":"Yao","year":"2015","journal-title":"Nat Commun"},{"key":"20","doi-asserted-by":"publisher","first-page":"e70117","DOI":"10.1371\/journal.pone.0070117","article-title":"Cisplatin and doxorubicin induce distinct mechanisms of ovarian follicle loss; imatinib provides selective protection only against cisplatin.","volume":"8","author":"Spears","year":"2013","journal-title":"PLoS One"},{"key":"21","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1200\/JCO.1985.3.2.237","article-title":"High-dose cisplatin with sodium thiosulfate protection.","volume":"3","author":"Murphy","year":"1985","journal-title":"J Clin Oncol"},{"key":"22","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.toxlet.2014.03.022","article-title":"Assessing cisplatin-induced ototoxicity and otoprotection in whole organ culture of the mouse inner ear in simulated microgravity.","volume":"22","author":"L\u00f6wenheim","year":"2014","journal-title":"Toxicol Lett"},{"key":"23","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1038\/nprot.2009.191","article-title":"Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo.","volume":"4","author":"Toussaint","year":"2009","journal-title":"Nat Protoc"},{"key":"24","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1093\/toxsci\/kfj086","article-title":"Characterizing the ovotoxicity of cyclophosphamide metabolites on cultured mouse ovaries.","volume":"9","author":"Devine","year":"2006","journal-title":"Toxicol Sci"},{"key":"25","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1007\/978-1-349-03328-7_8","article-title":"Quantitation by gas chromatography-chemical ionization mass spectrometry of cyclophosphamide, phosphoramide mustard, and nornitrogen mustard in the plasma and urine of patients receiving cyclophosphamide therapy.","volume":"3","author":"Colvin","year":"1978","journal-title":"Cancer Res"},{"key":"26","doi-asserted-by":"publisher","first-page":"140284","DOI":"10.1155\/2012\/140284","article-title":"On the discovery, biological effects, and use of Cisplatin and metallocenes in anticancer chemotherapy.","volume":"201","author":"Kalu\u0111erovi\u0107","year":"2012","journal-title":"Bioinorg Chem Appl"},{"key":"27","doi-asserted-by":"publisher","first-page":"7265","DOI":"10.1038\/sj.onc.1206933","article-title":"Cisplatin: mode of cytotoxic action and molecular basis of resistance.","volume":"2","author":"Siddik","year":"2003","journal-title":"Oncogene"},{"key":"28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s10557-016-6711-0","article-title":"Anthracycline Chemotherapy and Cardiotoxicity.","volume":"3","author":"Yellon","year":"2017","journal-title":"Cardiovasc Drugs Ther"},{"key":"29","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1097\/FPC.0b013e32833ffb56","article-title":"Doxorubicin pathways: pharmacodynamics and adverse effects.","volume":"2","author":"Altman","year":"2011","journal-title":"Pharmacogenet Genomics"},{"key":"30","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrc2167","article-title":"The resurgence of platinum-based cancer chemotherapy.","volume":"7","author":"Kelland","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"31","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/cdd.2010.139","article-title":"PTEN status switches cell fate between premature senescence and apoptosis in glioma exposed to ionizing radiation.","volume":"1","author":"Lee","year":"2011","journal-title":"Cell Death Differ"},{"key":"32","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41556-018-0249-2","article-title":"The dynamic nature of senescence in cancer.","volume":"2","author":"Schmitt","year":"2019","journal-title":"Nat Cell Biol"},{"key":"33","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3389\/fonc.2017.00278","article-title":"The Dual Role of Cellular Senescence in Developing Tumors and Their Response to Cancer Therapy.","volume":"7","author":"Breitenbach","year":"2017","journal-title":"Front Oncol"},{"key":"34","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.cell.2013.10.050","article-title":"A new development in senescence.","volume":"15","author":"Lowe","year":"2013","journal-title":"Cell"},{"key":"35","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrc2560","article-title":"Senescence-messaging secretome: SMS-ing cellular stress.","volume":"9","author":"Peeper","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"36","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.15252\/embr.201439245","article-title":"Senescence and apoptosis: dueling or complementary cell fates?","volume":"1","author":"van Deursen","year":"2014","journal-title":"EMBO Rep"},{"key":"37","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1083\/jcb.201009094","article-title":"Four faces of cellular senescence.","volume":"19","author":"Campisi","year":"2011","journal-title":"J Cell Biol"},{"key":"38","doi-asserted-by":"publisher","first-page":"3954","DOI":"10.1182\/blood-2003-04-1296","article-title":"Kit regulatory elements required for expression in developing hematopoietic and germ cell lineages.","volume":"10","author":"Ottolenghi","year":"2003","journal-title":"Blood"},{"key":"39","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.bcp.2008.03.025","article-title":"Histone H2AX phosphorylation as a molecular pharmacological marker for DNA interstrand crosslink cancer chemotherapy.","volume":"7","author":"Hartley","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"40","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/cyto.b.20450","article-title":"Kinetics of H2AX phosphorylation after exposure to cisplatin.","volume":"7","author":"Ban\u00e1th","year":"2009","journal-title":"Cytometry B Clin Cytom"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.102476","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T19:40:34Z","timestamp":1599075634000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.102476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,11]]},"references-count":40,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2019,11,30]]}},"alternative-id":["102476","31711044"],"URL":"https:\/\/doi.org\/10.18632\/aging.102476","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,11]]}}}